<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00298857</url>
  </required_header>
  <id_info>
    <org_study_id>05.02.045</org_study_id>
    <nct_id>NCT00298857</nct_id>
  </id_info>
  <brief_title>A Pharmacokinetic Study to Compare the Dosing of Valproic Acid in Subjects With Different Body Weights</brief_title>
  <official_title>An Open-label, Prospective Trial to Determine the Effect(s) of Obesity on the Pharmacokinetic Parameters of Valproic Acid</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwell Health</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the blood levels of valproic acid in subjects with&#xD;
      different body weights and to evaluate whether the pharmacokinetic parameters of this drug is&#xD;
      altered in the obese population.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Many pharmacologic agents are dosed based on the weight of the patient, and studies are&#xD;
      conducted to determine the appropriate doses of drugs for patients with different weights in&#xD;
      order to find the safest and most effective dose for various weights. Valproic acid is a&#xD;
      commonly used agent for the treatment of epilepsy, as well as migraine headaches and&#xD;
      psychiatric disorders. This prospective study is designed to evaluate the effects of obesity&#xD;
      on the pharmacokinetic parameters of valproic acid when compared to individuals at their&#xD;
      healthy weight.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of funding&#xD;
  </why_stopped>
  <start_date>March 2006</start_date>
  <completion_date type="Actual">March 2007</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area under the concentration time curve (AUC) from zero time to the 54-hour blood sampling and clearance in obese verses non-obese subjects after taking valproic acid.</measure>
  </primary_outcome>
  <enrollment>22</enrollment>
  <condition>Healthy</condition>
  <condition>Obesity</condition>
  <condition>Pharmacokinetics</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Valproic acid</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or Female age 21-60 years&#xD;
&#xD;
          -  Normal healthy volunteers as per interview at screening&#xD;
&#xD;
          -  Willing and able to provide written informed consent and comply with the study&#xD;
             protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to take oral medications&#xD;
&#xD;
          -  pregnant or lactating females&#xD;
&#xD;
          -  known hypersensitivity to valproic acid&#xD;
&#xD;
          -  BMI less than 18.5 kg/m^2&#xD;
&#xD;
          -  BMI between 25 and 29.9 kg/m^2, inclusive&#xD;
&#xD;
          -  Taking any drug or dietary supplement within one week prior to study period&#xD;
&#xD;
          -  Consumption of food 6 hours prior to study drug ingestion&#xD;
&#xD;
          -  Know family history or history of urea cycle disorders&#xD;
&#xD;
          -  Past history of pancreatitis&#xD;
&#xD;
          -  Past history of liver disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan Ettinger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>North Shore - Long Island Jewish Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Long Island Jewish Medical Center</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <study_first_submitted>March 2, 2006</study_first_submitted>
  <study_first_submitted_qc>March 2, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2006</study_first_posted>
  <last_update_submitted>June 29, 2012</last_update_submitted>
  <last_update_submitted_qc>June 29, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 3, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Healthy</keyword>
  <keyword>Obesity</keyword>
  <keyword>Pharmacokinetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Valproic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

